Behavioral responses induced by repeated treatment with methamphetamine alone and in combination with scopolamine in rats

Neuropsychobiology

Volumn 33, Issue 1, 1996, Pages 21-27

  Yui, Kunio ^a   Miura, Takao ^b  

^a Ministry of Justice   (Japan)

^b Namioka Town Hospital   (Japan)

Author keywords

Behavioral sensitization; Conditioned response; Dopaminergic dominance; Methamphetamine; Reciprocal balance; Scopolamine; Stereotyped behavior

Indexed keywords

AMPHETAMINE; METHAMPHETAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; AUDITORY STIMULATION; BEHAVIOR; CHOLINERGIC SYSTEM; CONDITIONED REFLEX; CONDITIONING; DOPAMINERGIC ACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTYPY;

ANIMALS; AROUSAL; ASSOCIATION LEARNING; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, CLASSICAL; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; INJECTIONS, INTRAPERITONEAL; MALE; METHAMPHETAMINE; MUSCARINIC ANTAGONISTS; RATS; RATS, WISTAR; SCOPOLAMINE; STEREOTYPED BEHAVIOR;

EID: 0030039506     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119244     Document Type: Article

References (37)

1. Robinson T, Becker JB: Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis, Brain Res Rev 1986:11:157-198.
2. Kilbey MM, Ellinwood EH: Reverse tolerance to stimulant-induced abnormal behavior, Life Sci 1977;20:1063-1076.
3. Klawans HL, Margolin DI: Amphetamine-induced dopaminergic hypersensitization in guinea pigs: Implications in psychosis and human movement disorders, Arch Gen Psychiatry 1975:32:725-732.
4. Kokkinidis L, Anisman H: Amphetamine models of paranoid schizophrenia: An overview and elaboration of animal experimentation, Psychol Bull 1980:88:551-579.
5. Karlcr R, Chaudhrv IA, Calder LD, Turkanis SA: Amphetamine behavioral sensitization and the excitatory amino acids, Brain Res 1990;537:76-82.
6. Carlton PL: Augmentation of the behavioral effects of amphetamine by scopolamine, Psy-chopharmacologia 1961;2:377-380.
7. Amfred T, Randrup A: Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behaviour, Acta Pharmacol Toxicol 1968;26:384-394.
8. Naylor RJ, Costall B: The relationship between the inhibition of dopamine uptake and the enhancement of amphetamine stereotypy, Life Sci 1971:10:909-915.
9. Costall B, Naylor RJ: Modification of amphetamine effects by intracercbrally administered anticholinergic agents, Life Sci 1972:11:239-253.
10. Yui K, Miura T, Fukushima T: Behavioral responses induced by mcthamphetamine administration in combination with scopolamine, Psychopharmacology 1988:96:167.
11. Yui K, Miura T: Cholinergic modulation on stereotyped behaviors and behavioral hypersensitivity (reverse tolerance) in rats, Jpn J Psy-chopharmacol 1991;11:141-156.
12. Tilson HA, Rech RH: Conditioned drug effects and absence of tolerance to β-amphetamine induced activity, Pharmacol Biochem Behav 1973:1:149-153.
13. Beninger RJ, Hahn BL: Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning, Science 1983:220:1304-1306.
14. Schiff SR: Conditioned dopaminergic activity, Biol Psychiatry 1982; 17:135-154.
15. Ellinwood EH: Accidental conditioning with chronic mcthamphetamine intoxication: Implication for a theory of drug habituation, Psy-chopharmacologia 1971:21:131-138.
16. Segal DS, Mandcll AJ: Long-term administration of β-amphetamine: Progressive augmentation of motor activity and stereotypy, Pharmacol Biochcm Behav 1974;2:249-255.
17. Robbins TW: Relationship between reward-enhancing and stereotypical effects of psychomotor stimulant drugs, Nature 1976:264:57-59.
18. Post RM, Lockfeld A, Squillace KM, Contel NR: Drug-cnvironment interaction: Context dependency of cocaine-induced behavioral sensitization, Life Sci 1980;28:755-760.
19. Utena H: On relapse-liability: Schizophrenia, amphetamine psychosis and animal model; in Mitsuda H, Fukuda T (eds): Biological mechanisms of schizophrenia and schizophrenia-like psychosis, Tokyo, Igaku-Shoin, 1974, pp285-287.
20. Schioring E: Psychopathology induced by ‘speed drugs’, Pharmacol Biochem Behav 1981:14:109-122.
21. Sato M, Chen C-C, Akiyama K, Otsuki S: Acute exacerbation of paranoid state after longterm abstinence in patients with previous methamphctantine psychosis, Biol Psychiatry 1983:18:429-440.
22. Paulson PE, Camp DM, Robinson TE: Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats, Psychopharmacology 1991; 103:480-492.
23. Yui K, Miura T, Sugivama K, Ono M, Nagase M: Stereotyped behavioral responses to an auditory stimulus in the course of repeated treatment with mcthamphetamine plus scopolamine and methamphetaminc in rats, Jpn J Psychopharmacol 1994:14:169-178.
24. Sahakian BJ, Robbins TW, Morgan MJ, Ivers-en SD: The effects of psychomotor stimulants on stereotypy and locomotor activity in socially-deprived and control rats, Brain Res 1975; 84:195-205.
25. Eichler AJ, Antclman SM, Black CK: Amphetamine stereotypy is not a homogenous phenomenon: Sniffing and licking show distinct profiles of sensitization and tolerance, Psychopharmacology 1980;68:287-290.
26. Kolta MG, Scalzo EM, Ali SF, Holson RR: Ontogeny of the enhanced behavioral response to apomorphine and amphetaminc-prctreatcd rats, Psychopharmacology 1990;100:377-382.
27. Ujike H, Akiyama K, Otsuki S: D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetaminc or cocaine, Psychopharmacology 1990; 102:459-464.
28. Carey RJ: Pavlovian conditioning between coadministered drugs: Elicitation of an apomor-phine-induced antiparkinsonian response by scopolamine, Psychopharmacology 1991:104: 463-469.
29. Freud JE: Modem Elementary Statistics, London, Prentice-Hall International, 1973.
30. Randrup A, Sorensen G, Kobayashi M: Stereotyped behaviour in animals induced by stimulant drugs or by a restricted cage environment: Rela:ion to disintegrated behaviour, brain dopamine and psychiatric disease, Jpn J Psychopharmacol 1988;8:313-327.
31. Ellinwood EH, Balster RL: Rating the behavioral effects of amphetamine, Eur J Pharmacol 1974;28:35-41.
32. Fray PJ, Sahakian BJ, Robbins TW, Koob GF, Iversen SD: An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of β-amphetamine and apomorphine, Psychopharmacology 1980;69:253-259.
33. Baldwin HA, Koob GF: Rapid induction of conditioned opiate withdrawal in the rat, Neuropsychopharmacology 1993;8:15-21.
34. Herz RS, Beninger RJ: Comparison of the ability of (+)-amphetamine and caffeine to produce environment-specific conditioning, Psychopharmacology 1987;92:365-370.
35. McKim WA: The effects of scopolamine on three different types of suppressed behavior of rats, Pharmacol Biochem Behav 1980; 12:409-412.
36. Harvey JA, Gormczano L, Cool-Hauser VA: Effects of scopolamine and methylscopolaminc on classical conditioning of the rabbit nictitating membrane response, J Pharmacol Exp Ther 1983:225:42-49.
37. Warburton DM, Groves PM: The effects of scopolamine on habituation of acoustic startle in rats, Commun Behav Biol 1969;3:289-293.